What Are the Sexual Side Effects of Trazodone?

Trazodone stands apart from most antidepressants in that its sexual side effects tend to be milder than those of widely prescribed SSRIs, but the drug carries a unique and serious risk: priapism, a prolonged, painful erection that constitutes a medical emergency. Beyond that headline risk, trazodone can affect desire, arousal, lubrication, and orgasm in both men and women, though the rates of these problems are generally lower than what patients experience on drugs like fluoxetine or sertraline. The full picture is more nuanced than “fewer side effects,” and whether trazodone helps or hinders your sex life depends on the dose, why you’re taking it, and what other medications are in the mix.

How Trazodone Compares to SSRIs on Sexual Function

One of trazodone’s selling points is that it tends to cause less sexual dysfunction than the SSRIs that dominate antidepressant prescribing. In a randomized controlled trial comparing trazodone head-to-head with fluoxetine and sertraline, patients on fluoxetine reported the most impairment in sexual desire, with roughly 43–51% of men and 44–50% of women affected. Trazodone produced the least desire-related impairment: about 12–18% of men and 23–24% of women reported problems. Men on trazodone also had lower rates of arousal and orgasm difficulties, in the range of 9–15%, compared to higher rates on the other two drugs.¹

Those numbers matter because sexual side effects are one of the top reasons people stop taking antidepressants. When a drug causes low libido, difficulty reaching orgasm, or erectile problems, patients often decide the cure feels worse than the disease. Trazodone’s comparatively lighter impact on sexual function is one reason clinicians sometimes recommend it, particularly for patients who have already had bad sexual experiences on an SSRI. That said, “lower rates” is not the same as “no risk.” Even in the trazodone group, some patients reported problems with desire and arousal, so this drug is not sexually inert.

Priapism in Men

The sexual side effect most closely associated with trazodone is priapism, a persistent erection lasting more than four hours that is unrelated to sexual arousal. A pharmacovigilance study using the FDA’s adverse event reporting system found that priapism was the most commonly reported reproductive-system adverse event linked to trazodone.² This is not a minor inconvenience. If left untreated, priapism can damage the tissue inside the penis, potentially leading to permanent erectile dysfunction. In rare cases involving patients with a history of blood clots, it has even led to the risk of penile amputation.

The underlying mechanism appears to involve trazodone’s ability to block alpha-adrenergic receptors in the smooth muscle of the penis. Normally, the sympathetic nervous system triggers the contraction of penile smooth muscle to end an erection. In a controlled study of healthy volunteers, trazodone significantly prolonged nocturnal erectile activity: on placebo, men averaged about 158–177 minutes of erectile activity per night, but on trazodone, that figure rose to 232–285 minutes. The detumescence phase, the period when an erection subsides, was prolonged by an average of 2.4 times compared to placebo. Laboratory tests on penile tissue confirmed that trazodone impaired the muscle contractions controlled by adrenergic nerves and blocked the effect of norepinephrine, the chemical signal responsible for ending erections.³

The practical takeaway is straightforward: any erection that persists for four hours or more while taking trazodone requires emergency medical attention. This is not a “wait and see” situation. Patients starting trazodone, particularly men, should be warned about this risk upfront. The incidence is relatively low in absolute terms, but the consequences of ignoring it are severe enough that awareness is essential.

Can It Happen in Women Too?

Priapism is not exclusively a male problem. Clitoral priapism, a persistent and painful engorgement of the clitoris, has been documented in women taking trazodone. In one published case, a woman experienced painful clitoral priapism lasting 24 hours that was attributed to trazodone. The clitoral tissue was not permanently damaged in that instance, and function appeared to recover.⁴ Clitoral priapism is far less commonly reported than penile priapism, but that may reflect underreporting rather than true rarity, since women’s genital side effects from medications have historically received less clinical attention.

Beyond priapism, women taking trazodone can experience changes in lubrication and arousal. However, these tend to be less frequently reported and less severe compared to SSRI-related sexual problems in women, which often involve difficulty reaching orgasm and significantly reduced desire. The randomized trial mentioned earlier found that about 23–24% of women on trazodone reported desire impairment, compared to 44–50% on fluoxetine.¹ So while trazodone is not free of effects in women, it generally performs better than the most commonly prescribed alternatives.

Effects on Ejaculation and Orgasm

Though trazodone is far less likely to delay orgasm than SSRIs, it is not immune to causing ejaculatory problems. A published case report described a male patient who developed ejaculatory inhibition, meaning he was unable to ejaculate despite arousal, while taking trazodone alongside several other medications. When trazodone was discontinued, ejaculatory function returned within 48 hours, strongly suggesting trazodone was the culprit.⁵

This is worth knowing because trazodone is sometimes prescribed specifically at bedtime for insomnia, often alongside other psychiatric medications. When a patient is on multiple drugs, teasing out which one is causing a sexual side effect can be tricky. The rapid reversal upon stopping trazodone in the case above is a useful clue for clinicians, and for patients who want to have an informed conversation with their prescriber about what might be going wrong.

Why Trazodone’s Pharmacology Creates This Unusual Profile

Most antidepressant-related sexual dysfunction traces back to serotonin. SSRIs flood the system with serotonin, which dampens libido, delays orgasm, and can make arousal harder to achieve. Trazodone works differently. It does increase serotonin activity to some extent, but it also blocks specific serotonin receptor subtypes (particularly 5-HT2A) and alpha-1 adrenergic receptors. The balance between these actions is what creates its distinctive sexual side-effect profile.

Research into trazodone’s receptor-binding behavior has shown that the doses required to occupy the receptors linked to sexual benefit (5-HT1A agonism and 5-HT2A antagonism) overlap with those causing sedation through histamine and alpha-1 blockade.⁶ This means the dose window where trazodone might actually improve sexual function without putting you to sleep or causing priapism is narrower than you might expect. At low doses, like the 25–100 mg range commonly used for insomnia, sedation is the dominant effect. At higher antidepressant doses (150–300 mg), both the sexual benefits and the risks, including priapism, become more pronounced.

Trazodone also has an active metabolite called mCPP, which interacts with serotonin receptors in a less predictable way, acting as a nonselective agonist with some antagonist properties and influencing hormones and behavior through central serotonin pathways.⁷ This metabolite may partly explain why some people experience unexpected sexual effects on trazodone, and why the drug’s impact on sexual function can be unpredictable from person to person.

Trazodone as a Treatment for Sexual Dysfunction

Here is where things get counterintuitive. The same drug that can cause priapism has been studied as a treatment for erectile dysfunction and for sexual problems caused by other antidepressants. This dual nature makes trazodone one of the more unusual medications in psychiatry.

When patients on SSRIs develop sexual dysfunction that they find intolerable, adding low-dose trazodone is one strategy clinicians have tried. A preliminary open-label study found that adding trazodone improved sexual function in both men and women who were experiencing SSRI-induced problems. Men saw improvements in erectile performance, while women noticed better lubrication. The improvements in sexual function did not correlate with changes in depression or anxiety, suggesting that trazodone was acting directly on sexual pathways rather than just improving mood.⁸

For erectile dysfunction specifically, however, the evidence is less clear-cut. A systematic review and meta-analysis pooling data from controlled trials found that men on trazodone were somewhat more likely to report improvement than those on placebo (about 37% versus 20%), but this difference was not statistically significant. There were hints that trazodone worked better for men whose erectile dysfunction had a psychological rather than physical origin, and that higher doses in the range of 150–200 mg per day were more effective than lower ones around 50 mg.⁹ A separate double-blind trial in a broader group of men with erectile dysfunction of various causes found no significant difference between trazodone 150 mg per day and placebo on subjective measures.¹⁰

In short, trazodone on its own is not a reliable standalone treatment for erectile dysfunction in the way that drugs like sildenafil are. But it may have a niche role, particularly for men whose problem is primarily psychological or who are dealing with SSRI-induced dysfunction.

Combining Trazodone with Other Sexual Health Medications

Some clinicians have explored combining trazodone with phosphodiesterase-5 inhibitors like sildenafil for men who did not respond to sildenafil alone. A pilot study of 18 men who had initially failed sildenafil monotherapy found that adding trazodone led to favorable outcomes in 12 of them, with those men continuing to enjoy good sexual activity on the combination. Two more showed marginal improvement, while four saw no benefit.¹¹

This combination approach is not widely adopted and should only be considered under medical supervision. The reason for caution is that both trazodone and sildenafil lower blood pressure, and combining them increases the risk of dizziness, fainting, or dangerous drops in blood pressure. The pilot study was small and the results were encouraging but preliminary, not the kind of evidence that supports routine use. If you’re interested in this kind of combination, it’s the sort of thing to discuss with a urologist or psychiatrist who has experience with both medications.

What To Do If Trazodone Is Affecting Your Sex Life

If you’re taking trazodone and noticing sexual side effects, there are several approaches your prescriber might consider. A clinical review of management strategies for antidepressant-related sexual dysfunction outlines the main options depending on the specific problem:¹²

Low desire: Switching to a different non-serotonergic antidepressant, reducing the dose, or adding bupropion or aripiprazole are common strategies.
Orgasm delay or anorgasmia: Dose reduction, taking a “weekend holiday” from the medication (skipping doses before planned sexual activity, only with your doctor’s guidance), or switching to a different antidepressant.
Erectile dysfunction: Switching medications, or adding a PDE5 inhibitor like sildenafil or tadalafil as an antidote.
Lubrication problems: Switching medications, lowering the dose, or using vaginal lubricants as a simple practical measure.

Because trazodone is already considered a “lower risk” antidepressant for sexual side effects, switching to it from an SSRI is itself one of the management strategies clinicians use. But if trazodone is the one causing the problem, switching away from it or adjusting the dose are reasonable steps. The key point is that sexual side effects from antidepressants are not something you have to silently endure. They are common, they are treatable, and raising them with your prescriber is the first step toward finding a solution that works for both your mental health and your sexual health.

The Dose Question

Trazodone’s sexual effects are strongly dose-dependent, which creates a paradox. At the low doses typically prescribed for insomnia (25–100 mg at bedtime), sexual side effects are uncommon, but the drug also does not provide much in the way of sexual benefit. At the higher doses used for depression (150–300 mg or more), the alpha-adrenergic blockade becomes stronger, which means the risk of priapism climbs and the potential pro-sexual effects (enhanced erection, improved arousal) also become more noticeable.

Research into trazodone’s receptor occupancy has raised the question of whether the drug is “underused and overdosed” in the context of sexual medicine, meaning that the therapeutic window for sexual benefit may sit at a dose lower than what’s typically prescribed for depression but higher than the insomnia dose.⁶ The challenge is that this middle-ground dose has not been well-studied in large trials, so clinicians are often working with incomplete information when trying to find the right balance for an individual patient.

For someone taking trazodone primarily for sleep, the good news is that the risk of significant sexual side effects at low doses is small. For someone taking it at full antidepressant doses, the risk profile changes, and a frank conversation with your prescriber about what to watch for becomes more important.

When Trazodone Is Taken Without a Prescription

Trazodone has a reputation in some circles as a drug that enhances erections, which has led to off-label or non-prescribed use by people seeking sexual performance benefits. This is a genuinely dangerous idea. The same alpha-blocking properties that can enhance erections are the ones that cause priapism, and without medical monitoring, a person has no way to calibrate the dose to stay on the safe side of that line. Priapism from trazodone is not a theoretical risk; it is the most commonly reported reproductive adverse event in FDA databases, and it can cause irreversible damage within hours.² Anyone considering using trazodone purely for sexual purposes without a prescription is taking a gamble with consequences that are both serious and permanent.

There is also the sedation issue. Trazodone is a strong sedative at even moderate doses, which is why it’s so widely used for insomnia. Using it recreationally for sexual enhancement means you’re also taking a drug that is likely to make you drowsy, impair coordination, and potentially drop your blood pressure, none of which are compatible with a good sexual experience or good decision-making. The risk-benefit calculus simply does not favor unsupervised use.